ArticlePloS one2021
Synergistic effects of Cu-doped ZnO nanoantibiotic against Gram-positive bacterial strains.
Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 90 citations in OpenAlex.
- Integrated Electrochemical and Biomedical Properties of Cu-Doped ZnO NPs Synthesized via Green Methods.ACS omega · 2026Article
- Comparative Study of Hydrothermal and Sonochemical Preparation of Cu and Ag Codoped ZnO/Graphene Nanocomposites for Enhanced Catalytic and Inactivation of Pathogens.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026Article
- Article
- Study of antibacterial activity of copper zinc nanocomposites and disruption of bacterial cytoplasmic membrane.Scientific reports · 2025Article
- Cu-ZnO Embedded in a Polydopamine Shell for the Generation of Antibacterial Surgical Face Masks.Molecules (Basel, Switzerland) · 2024Article
- Article
- NIR light-activated nanocomposites combat biofilm formation and enhance antibacterial efficacy for improved wound healing.Communications chemistry · 2024Article
- Formulation and evaluation of azithromycin-loaded silver nanoparticles for the treatment of infected wounds.International journal of pharmaceutics: X · 2024Article
- Ginger (ACS omega · 2024Article
- The high impact of zinc chromium oxide nanocombs on development of larvicidal and antimicrobial performance.BMC chemistry · 2024Article
- Bioinspired palladium-doped manganese oxide nanocorns: a remarkable antimicrobial agent targeting phyto/animal pathogens.Scientific reports · 2023Article
- Optically amended biosynthesized crystalline copper-doped ZnO for enhanced antibacterial activity.RSC advances · 2023Article
- Synthesis, Characterization, and Evaluation of Antimicrobial Efficacy of Reduced Graphene-ZnO-Copper Nanocomplex.Antibiotics (Basel, Switzerland) · 2023Article
- Optimization of physical and dielectric properties of Co-doped ZnO nanoparticles for low-frequency devices.PloS one · 2023Article
- In Vitro Influence of ZnO, CrZnO, RuZnO, and BaZnO Nanomaterials on Bacterial Growth.Molecules (Basel, Switzerland) · 2022Article
- Antibacterial and Photocatalytic Coatings Based on Cu-Doped ZnO Nanoparticles into Microcellulose Matrix.Materials (Basel, Switzerland) · 2022Article
- Application of Nanomaterials in the Prevention, Detection, and Treatment of Methicillin-ResistantPharmaceutics · 2022Review
- Photocatalytic properties of Cu-containing ZnO nanoparticles and their antifungal activity against agriculture-pathogenic fungus.RSC advances · 2022Article
- Cytotoxic and photocatalytic studies of hexagonal boron nitride nanotubes: a potential candidate for wastewater and air treatment.RSC advances · 2022Article
- Insights into ZnO-based doped porous nanocrystal frameworks.RSC advances · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A viable hydrothermal technique has been explored for the synthesis of copper doped Zinc oxide nanoparticles (Cu-doped ZnO-NPs) based on the precursor's mixture of Copper-II chloride dihydrate (CuCl2.2H2O), Zinc chloride (ZnCl2), and potassium hydroxide (KOH). X-ray diffraction (XRD) reported the hexagonal wurtzite structure of the synthesized Cu-doped ZnO-NPs. The surface morphology is checked via field emission scanning electron microscopy (FE-SEM), whereas, the elemental compositions of the samples were confirmed by Raman, and X-ray photoelectron spectroscopy (XPS), respectively. The as-obtained ZnO-NPs and Cu-doped ZnO-NPs were then tested for their antibacterial activity against clinical isolates of Gram-positive (Staphylococcus aureus, Streptococcus pyogenes) and Gram-negative (Escherichia coli, Klebsiella pneumonia) bacteria via agar well diffusion method. The zone of inhibition (ZOI) for Cu-doped ZnO-NPs was found to be 24 and 19 mm against S. Aureus and S. pyogenes, and 18 and 11 mm against E. coli and K. pneumoniae, respectively. The synthesized Cu-doped ZnO-NPs can thus be found as a potential nano antibiotic against Gram-positive multi-drug resistant bacterial strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.